Aspira Women's Health Expands Senior Leadership Team
Aspira Women’s Health expands senior management team with the addition of Sandra Milligan, MD, JD as President effective April 1, 2024. Dr. Milligan will report to CEO Nicole Sandford. She has more than 25 years of experience in the healthcare sector, with corporate experience that includes executive roles at biopharmaceutical companies Amgen, Genentech, Merck, and Organon. Dr. Milligan supported pipeline and product development in both oncology and non-oncology disease areas, with recent emphasis in women’s health. She earned a Doctor of Medicine from the George Washington University of Medicine as well as a Juris Doctor from Georgetown University Law Center. As President, Dr. Milligan will be a key member of the executive leadership team, with direct responsibility for R&D, Operations, Information Technology, and Human Resources. Her immediate focus will be on accelerating the launch of the company’s in-development products and identification of potential innovation and commercialization partnerships. Aspira also announced today that Dr. Todd Pappas, Vice President of Research and Development, has assumed responsibilities for product development, replacing Dr. Jody Berry, who stepped down earlier this month. Dr. Pappas first joined Aspira in 2013 and has experience in R&D, commercial, and clinical operations at Aspira, Delphi, Inc. Reliant Immune Diagnostics, and Luminex Corporation. His work has been central to the successful development of the OvaSuite test portfolio. Dr. Pappas will continue to be responsible for all aspects of Aspira’s scientific and product development activities and its relationships with academic partners, including Dana-Farber Cancer Institute. Dr. Pappas received his Ph.D. in Neuroscience from the University of Texas Medical Branch at Galveston, and an MS in Biology from California State University, Long Beach.
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.